ArticleAmerican journal of translational research2020

Ceramide synthase 6 predicts poor prognosis and activates the AKT/mTOR/4EBP1 pathway in high-grade serous ovarian cancer.

Yinong Shi et al.PubMed ↗Full text ↗

No numbers read from the abstract.